Publication
Article
FACULTY
Michael Heile, MD, FAAFP
TriHealth Physician Partners
Cincinnati, OH
Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP
Senior Director
Clinical Analytics
WellDyne
Lakeland, FL
Tanya Dougherty, PharmD, BCPS
Population Health Pharmacist
Jefferson Health
Philadelphia, PA
Helena W. Rodbard, MD, FACP, MACE
Medical Director
Endocrine and Metabolic Consultants
Rockville, MD
Ildiko Lingvay, MD, MPH, MSCS
Professor of Medicine
Department of Internal Medicine/Endocrinology
Department of Population and Data Sciences
University of Texas Southwestern Medical Center
Dallas, TX
Doron Schneider, MD
Vice President
Population Health Services
Tandigm Health
Conshohocken, PA
FACULTY DISCLOSURES
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Michael Heile, MD, FAAFP
SPEAKER
Novo Nordisk Inc
STOCK OWNERSHIP
Novo Nordisk Inc
Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP
ADVISORY BOARD
Novo Nordisk
Helena W. Rodbard, MD, FACP, MACE
CONSULTANT
AstraZeneca; Boehringer Ingelheim; Janssen; Lexicon; Lilly; Merck; Novo Nordisk Inc; Sanofi
GRANT SUPPORT
AstraZeneca; Boehringer Ingelhein; Janssen; Lexicon; Lilly; Novo Nordisk Inc; Sanofi
ADVISORY BOARD
Merck
Ildiko Lingvay, MD, MPH, MSCS
GRANT SUPPORT
GI Dynamics; Merck; Mylan; Novartis; Novo Nordisk Inc; Pfizer
CONSULTANT
AstraZeneca; Boehringer Ingelheim; Duke CRI; Eli Lilly; Intarcia; Intercept; Janssen; Mannkind; Novo Nordisk Inc; Sanofi; TARGETPharma; Valeritas; Zealand
Doron Schneider, MD
SPEAKER
Novo Nordisk Inc
CONSULTANT
Eli Lilly; HealthCast
Tanya Dougherty, PharmD, BCPS
reports no relevant financial relationships with commercial interests.